ArticleNeurosurgical review2026
Risk factors to guide Terson syndrome screening after aneurysmal subarachnoid Hemorrhage.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Terson syndrome is defined as intraocular hemorrhage secondary to aneurysmal subarachnoid hemorrhage (aSAH). Despite clinical relevance, it remains under-recognized and is associated with poorer neurological and visual outcomes. Early detection is difficult in critically ill patients unable to report symptoms. We aimed to identify independent predictors and develop a clinically usable risk score for targeted ophthalmologic screening. We conducted a retrospective cohort study of 220 adult aSAH patients admitted to Odense University Hospital (Sept 1, 2018-Jan 21, 2025), of whom 89 underwent ophthalmologic screening. Terson syndrome was defined as any intraocular hemorrhage on examination. Predictors were selected using least absolute shrinkage and selection operator (LASSO) logistic regression, with multivariable analysis and internal validation via bootstrapping. A point-based risk score was derived and compared to a literature-based model using discrimination, calibration, information criteria, and decision curve analysis. Sensitivity analyses included Firth logistic regression and inverse probability weighting. Among 220 patients, 89 (40.5%) were screened; 31 had Terson syndrome (14.1% overall; 34.8% of screened). Three predictors were identified: male sex (OR 10.9), higher Hunt-Hess grade (OR 3.0 per grade), and anterior communicating artery aneurysm (OR 8.6; all p < 0.05). The model demonstrated strong discrimination (AUC 0.862; 95% CI, 0.787-0.937), good calibration, and outperformed the literature-based comparator (AUC 0.769). A 0-7 point-based score stratified risk from < 25% to > 80%, with superior net benefit. Sensitivity analyses confirmed robustness. This three-variable model offers a pragmatic tool for early Terson syndrome detection and may reduce preventable visual morbidity through targeted screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.